Hospice Recertification Narrative Examples: A 2026 Guide for Hospice Clinicians

Quick Answers: Hospice Recertification Narratives

What is a hospice recertification narrative?

A hospice recertification narrative is a written, signed statement from the certifying physician explaining why a patient continues to have a life expectancy of six months or less if their terminal illness runs its normal course. It is required at the start of each benefit period after the first 90-day period, lives in the medical record, and must be specific to the individual patient — not a template, a checklist, or a copy of prior documentation. The requirement comes from 42 CFR 418.22(b)(3).

Who writes the recertification narrative?

The hospice physician (medical director or designee) writes and signs the narrative. The narrative is a physician composition — not a nurse note rolled forward — even though the underlying clinical evidence is typically gathered by the case manager during the recertification visit. The physician must personally compose the prognosis statement based on the clinical evidence.

What makes a recertification narrative compliant?

A compliant narrative ties patient-specific clinical findings (weight loss, decline in functional status, recurrent infections, increased symptom burden) to a stated six-month prognosis, uses the patient's own trajectory rather than generic disease language, and is signed and dated by the certifying physician before the start of the new benefit period. Notes that read identically across multiple recertifications, or that contain only diagnostic codes and vital signs, are the most common cause of Additional Documentation Request (ADR) denials.

How long should a recertification narrative be?

There is no minimum length in regulation, but compliant narratives are typically 150–300 words. Length is not the standard. Specificity is. A 120-word narrative with three patient-specific decline indicators and a clear prognosis statement will survive review. A 500-word narrative of copy-pasted disease descriptions will not.

Why Recertification Narratives Matter More in 2026

The recertification narrative is the single document most likely to be requested in a Medicare Administrative Contractor (MAC) audit and the single document most likely to cause a denial when it is requested. The reason is simple: it is the only physician-authored document in the chart that directly attests to continued hospice eligibility. Everything else — the certification of terminal illness, the face-to-face encounter, the IDG plan of care — supports the prognosis, but the recertification narrative is the prognosis.

FY 2026 has raised the stakes. The FY 2026 Hospice Final Rule (CMS-1835-F) clarified face-to-face attestation requirements, raised the hospice aggregate cap to $35,361.44, and reaffirmed the medical director's central role in admission and recertification. The Hospice Special Focus Program (HSFP) is paused but MAC-led audit activity — Targeted Probe and Educate (TPE), provisional period of enhanced oversight (PPEO), and 5-day post-payment review programs — continues at high intensity. Hospice News reported in March 2026 that fraud-fight rhetoric from CMS leadership has reached a level where "no one is safe" from review.

None of that should change the work of taking care of the patient. It should change how that work is documented.

What CMS Requires in a Hospice Recertification Narrative

Three regulatory sources govern the recertification narrative:

• 42 CFR 418.22(b)(3) — requires the physician's written or computer-generated signature on a brief narrative explaining the clinical findings that support a life expectancy of six months or less.
• 42 CFR 418.25 — sets the structure of the benefit periods: two 90-day periods followed by an unlimited number of 60-day periods. A recertification is required at the start of each period after the first.
• CMS Internet-Only Manual (IOM) Publication 100-02, Chapter 9 — operationalizes the regulation, including the requirement that the narrative reflect the physician's review of the medical record and be patient-specific.

The narrative must include a statement attesting that the narrative was composed based on the physician's review of the medical record or examination of the patient. Standard EMR macros frequently omit this attestation; auditors look for it.

The Four Elements Every Recertification Narrative Should Contain

A defensible narrative is built on four pillars. If any of the four is missing, the narrative is vulnerable to an ADR denial regardless of how clinically appropriate the hospice election actually is.

1. The terminal diagnosis and its current trajectory

State the principal terminal diagnosis using ICD-10-CM specificity (G30.9 for unspecified Alzheimer's disease, I50.84 for end-stage heart failure, C80.1 for malignant neoplasm without specification). Then describe where the patient is on the disease trajectory now, not at admission. "Continued decline" is not a trajectory description. "FAST 7c with new urinary incontinence and 6-pound weight loss over the past 30 days" is.

2. Patient-specific decline indicators since the last certification

This is the section auditors read first. Use objective, measurable markers from the current benefit period: weight changes, Palliative Performance Scale (PPS) drops, increases in symptom burden, new hospitalizations or ER visits, new wounds, new infections, increasing oxygen requirements, new medications added for symptom management. Each decline indicator should be tied to a specific date or visit.

3. Supporting comorbidities

Comorbidities support the terminal prognosis when they accelerate decline or increase symptom burden related to the terminal illness. List them by ICD-10 code and explain the contribution. "CAD, DM, HTN" is a problem list. "End-stage heart failure (I50.84) complicated by chronic kidney disease stage 4 (N18.4), which limits diuretic optimization and contributes to recurrent decompensation" is a clinical narrative.

4. The prognosis statement and attestation

Close with an explicit statement that the patient's life expectancy is six months or less if the terminal illness runs its normal course, and an attestation that the narrative is based on the physician's review of the medical record or examination of the patient. Sign and date before the start of the new benefit period.

Three Worked Recertification Narrative Examples

The narratives below are written for illustration. Names, dates, and identifiers are fictional. They demonstrate structure and language, not specific clinical decisions for a specific patient.

Example 1 — End-Stage Heart Failure (third benefit period)

Mr. R is a 78-year-old male with end-stage heart failure (I50.84) recertified for his third benefit period. Since the prior recertification on January 14, 2026, the patient has experienced continued decline characterized by: (1) two emergency department visits for acute volume overload (February 3 and March 11, 2026) without hospital admission per patient and family wishes; (2) a documented weight loss of 9 pounds over the past 60 days despite stable appetite, consistent with cardiac cachexia; (3) progression from PPS 50% to PPS 30%, with the patient now bed-bound for greater than 50% of waking hours; (4) escalation of furosemide from 40 mg twice daily to 80 mg twice daily with the addition of metolazone 5 mg every other day; (5) new dyspnea at rest documented at the March 18 RN visit.

Supporting comorbidities include chronic kidney disease stage 4 (N18.4), which limits further diuretic optimization, and chronic atrial fibrillation with rate control on amiodarone. The combination of accelerated functional decline, recurrent decompensation, and ceiling on medical management indicates that the patient's life expectancy is six months or less if the terminal illness runs its normal course.

This narrative is composed based on my review of the medical record, including the most recent RN visit notes, the IDG summary of March 19, 2026, and the patient's medication administration record.

— Jane Park, MD, Hospice Medical Director. Signed and dated April 14, 2026.

Example 2 — Alzheimer's Dementia (fifth benefit period)

Mrs. T is an 86-year-old female with end-stage Alzheimer's-type dementia (G30.9) recertified for her fifth benefit period. The patient meets FAST stage 7c with the following patient-specific findings documented since the prior recertification on February 10, 2026: (1) new urinary incontinence as of the March 4 visit; (2) progression to assistance required for all transfers and inability to ambulate even with two-person assist; (3) speech limited to single-word responses, down from short phrases at prior recertification; (4) 7-pound weight loss over 60 days despite caregiver use of pureed diet and supplemental nutrition; (5) one episode of aspiration pneumonia (March 22, 2026) treated at home per advance directive with oral antibiotics and nebulized treatments.

Supporting comorbidities include recurrent aspiration risk related to dysphagia, Stage 2 sacral pressure injury (L89.152) present on admission to this benefit period and unhealed at recertification, and protein-calorie malnutrition (E44.0). The combination of the patient's FAST 7c status, new functional losses, recent aspiration event, and progressive weight loss indicates that the patient's life expectancy is six months or less if the terminal illness runs its normal course.

This narrative is composed based on my review of the medical record and the IDG discussion of April 9, 2026.

— Jane Park, MD, Hospice Medical Director. Signed and dated April 14, 2026.

Example 3 — Adult Failure to Thrive / Debility (second benefit period)

Adult failure to thrive (R62.7) and debility unspecified (R53.81) are the highest-audit-risk terminal diagnoses in hospice because they describe a syndrome rather than a discrete disease process. CMS has explicitly stated these diagnoses should not be used as principal terminal diagnoses except in narrow circumstances; when they are used, the recertification narrative must do extra work to demonstrate the clinical trajectory.

Mr. K is an 81-year-old male admitted with adult failure to thrive (R62.7) recertified for his second benefit period. The hospice IDG has carefully reviewed the principal terminal diagnosis at this recertification and continues to support its use based on the patient's multi-system decline that does not map cleanly to a single end-stage organ disease. Since the prior certification on January 14, 2026, the patient has experienced: (1) weight loss of 12 pounds (from 142 lb to 130 lb), now meeting criteria for severe protein-calorie malnutrition; (2) progression from PPS 40% to PPS 20%, with the patient now totally bed-bound and dependent for all ADLs; (3) two episodes of recurrent UTI with delirium (February and March 2026); (4) Stage 3 sacral pressure injury (L89.153), newly developed since admission despite repositioning and pressure-redistribution mattress; (5) progressive dysphagia with documented coughing during meals as of the April 1 visit.

Supporting comorbidities include severe protein-calorie malnutrition (E43), chronic kidney disease stage 3b (N18.32), and recurrent urinary tract infections (N39.0). Together, these findings demonstrate that the patient's life expectancy is six months or less if the underlying syndrome runs its normal course.

This narrative is composed based on my review of the medical record, the most recent RN and HHA visit notes, and the patient's most recent weights documented April 1, 2026.

— Jane Park, MD, Hospice Medical Director. Signed and dated April 14, 2026.

Common ADR Triggers in Recertification Narratives — and How to Avoid Them

The following are the most frequently cited deficiencies in MAC reviews of hospice recertifications. Each is preventable.

• Identical narratives across benefit periods. The fastest way to fail an audit. If two recertifications for the same patient are textually identical, the reviewer assumes the second was not based on a fresh medical-record review. Always reference the prior benefit period explicitly ("since the prior recertification on...") and include at least three new patient-specific findings.
• Generic disease language. "Continued decline consistent with end-stage dementia" is generic. "FAST 7c with new urinary incontinence as of March 4, 2026 and a 7-pound weight loss over 60 days" is patient-specific. Replace every generic phrase with a dated observation.
• Missing attestation. The phrase "this narrative is composed based on my review of the medical record or examination of the patient" is non-optional. Build it into the physician's template.
• Signed and dated after the start of the new benefit period. A narrative dated after day 1 of the new period creates a coverage gap. Track recertification dates and route the narrative for signature 7–14 days before the benefit period rolls.
• No tie to the principal terminal diagnosis. If the patient was admitted with end-stage heart failure, the narrative should principally describe cardiac decline. Comorbidities support; they do not replace.
• Use of debility or AFT without justification. If R62.7 or R53.81 is the principal terminal diagnosis, the narrative must explicitly justify the use of a syndrome-level diagnosis and demonstrate multi-system decline.

An AI-Assisted Recertification Workflow on Hathr.AI

The recertification narrative is a physician composition. It cannot be outsourced to a language model and signed without review. What a HIPAA-compliant AI tool can do is shrink the time between "I need to recertify this patient" and "I have a draft to review" from 25 minutes to 6 minutes — and it can do it without exposing PHI to a consumer chat product.

Hathr.AI runs on AWS GovCloud (FedRAMP High) — the same environment used by the Department of Health and Human Services — and signs a Business Associate Agreement with every plan. Patient data is never used to train the underlying model. ChatGPT, Claude.ai, and Gemini cannot make any of those statements. For PHI work, the platform you use matters as much as the prompt.

A representative recertification workflow on Hathr.AI:

1. Assemble the source documents. The case manager uploads the prior recertification narrative, the most recent RN visit note, the most recent IDG summary, the medication administration record, and any hospital or ER discharge summaries from the current benefit period.
2. Generate the decline-indicator summary. Prompt: "From the attached records, extract every patient-specific decline indicator observed since [prior recertification date]. Include dates, measurements, and source document for each finding. Do not include findings prior to that date."
3. Draft the narrative. Prompt: "Using the decline indicators above, draft a hospice recertification narrative for a patient with [principal terminal diagnosis, ICD-10]. Follow this structure: terminal diagnosis and current trajectory; patient-specific decline indicators since the prior recertification; supporting comorbidities by ICD-10 code; prognosis statement; attestation that the narrative is based on physician review of the medical record. Target 200–250 words."
4. Physician review. The medical director reads the draft against the source documents, edits for accuracy, confirms each cited finding, adds clinical judgment that did not appear in the records, and signs.

This workflow does not reduce physician responsibility. The narrative remains the physician's composition; the AI surfaces the evidence and proposes language, the physician validates and commits. The result is a draft that is faster to produce, more specific to the patient, and easier to defend on review.

Frequently Asked Questions

Does the recertification narrative require a face-to-face encounter?

A face-to-face encounter is required for the third and every subsequent benefit period — that is, at the start of the third benefit period and at each recertification thereafter. The encounter must occur within the 30 days prior to the start of the benefit period and must be performed by a hospice physician or a hospice-employed nurse practitioner. The FY 2026 Hospice Final Rule clarified that a signed and dated clinical note can satisfy the face-to-face attestation requirement, but the narrative itself is a separate document.

Can a nurse practitioner write the recertification narrative?

No. Although NPs may perform the face-to-face encounter, only a physician (the hospice medical director or a designee) may compose and sign the recertification narrative. This is established in 42 CFR 418.22 and 418.25.

What happens if the recertification narrative is missing or non-compliant?

A missing or non-compliant narrative is a frequent basis for denial of an entire benefit period. On post-payment review, the MAC may recoup all payments for the affected period. On TPE, repeated narrative deficiencies in Round 1 lead to Round 2 and possibly Round 3, with progressive escalation up to and including potential referral for further enforcement action.

How often should the medical director review the principal terminal diagnosis?

At every recertification, the medical director should reconfirm that the principal terminal diagnosis remains the best fit for the patient's clinical trajectory. If the patient's decline is now driven by a different end-stage process, the principal diagnosis should be updated and the change documented.

Can AI replace the physician's role in writing the narrative?

No, and no responsible hospice should attempt it. AI can summarize source records, surface decline indicators, and propose draft language. The physician's role — to apply clinical judgment, to validate the findings against the patient's actual trajectory, and to sign as the certifying provider — cannot be delegated to software. Hathr.AI accelerates the work without replacing the physician's responsibility for it.

Sources and Further Reading

• 42 CFR 418.22 — Certification of terminal illness
• 42 CFR 418.25 — Admission to hospice care
• CMS IOM Publication 100-02, Chapter 9 — Coverage of Hospice Services
• FY 2026 Hospice Wage Index and Payment Rate Update Final Rule (CMS-1835-F)
• State Operations Manual Appendix M — Guidance to Surveyors: Hospice

This article is for informational purposes only and does not constitute legal, clinical, or billing advice. Hospice agencies should consult their compliance and clinical leadership before adopting any documentation practice. Last reviewed: May 2026.

Ready to see how a HIPAA-compliant AI workflow handles your recertification queue? Start a 7-day free trial of Hathr.AI — the only generative AI built on AWS GovCloud (FedRAMP High), with a signed BAA included on every plan.